SCHEMBL3677997

SCHEMBL3677997

O=[N+]([O-])c1c(O)cccc1I

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 2/20 0.62
▸ ALDH1A1 P00352 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ S100A4 P26447 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TSHR P16473 3/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ TLR8 Q9NR97 1/20 0.38
▸ CTSB P07858 1/20 0.37
▸ CSNK2A2 P19784 2/20 0.37
▸ CSNK2B P67870 2/20 0.37
▸ CSNK2A1 P68400 2/20 0.37
▸ CSNK2A3 Q8NEV1 2/20 0.37
▸ KCNMA1 Q12791 1/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70533 0.84 GPR35 (0.75) GPR35ALDH1A1TDP1S100A4LMNA
SCHEMBL14054978 0.84 ALDH1A1 (0.52) GPR35ALDH1A1TDP1S100A4LMNA
SCHEMBL1162131 0.79 GPR35 (0.62) GPR35ALDH1A1TDP1S100A4LMNA
SCHEMBL29516730 0.77 GPR35 (1.00) GPR35ALDH1A1TDP1S100A4TSHR
SCHEMBL16979 0.77 GPR35 (1.00) GPR35ALDH1A1TDP1S100A4TSHR
SCHEMBL1056952 0.77 TDP1 (0.45) GPR35ALDH1A1TDP1S100A4LMNA
SCHEMBL9860246 0.77 TSHR (0.59) GPR35ALDH1A1TDP1S100A4MEN1
SCHEMBL310877 0.76 TSHR (0.51) GPR35ALDH1A1TDP1MEN1KMT2A
SCHEMBL28335654 0.75 GPR35 (0.47) GPR35ALDH1A1TDP1S100A4LMNA
SCHEMBL3751802 0.75 GPR35 (0.47) GPR35ALDH1A1S100A4LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122055148-A Conjugates, compositions and methods for treating influenza 珀杜研究基金会 2026-05-15 — — CN claimed
CN-120018779-A Feed and method for controlling infection of central filarial in mammals 碗中动物健康公司 2025-05-16 — — CN claimed
WO-2025085675-A1 CONJUGATES, COMPOSITIONS AND METHODS FOR TREATING RSV INFECTION NIEDRAUER MARY LYNN (US) 2025-04-24 — — WO claimed
WO-2025085664-A1 CONJUGATES, COM POSITIONS AND METHODS FOR TREATING INFLUENZA NIEDRAUER MARY LYNN (US) 2025-04-24 — — WO claimed
CN-112972437-B Long-acting external preparation containing iodonitrophenol and preparation method and application thereof 沈阳伟嘉生物技术有限公司 2022-03-25 — — CN claimed
CN-112972437-A Long-acting external preparation containing iodonitrophenol and preparation method and application thereof 沈阳伟嘉生物技术有限公司 2021-06-18 — — CN claimed
CN-109776498-A A kind of preparation method of Cilostazol 浙江永宁药业股份有限公司 2019-05-21 — — CN claimed
CN-116969925-B Heteroaryl-triazole compounds BAYER AG (DE) 2026-05-26 — — CN disclosed
CN-122055148-A Conjugates, compositions and methods for treating influenza 珀杜研究基金会 2026-05-15 — — CN disclosed
EP-4716745-A1 NEW TLR-4 ANTAGONIST APTAMERS Merck Patent GmbH (DE) 2026-04-01 — — EP disclosed
WO-2026044019-A1 COMPOSITIONS AND METHODS FOR TREATING INFLUENZA INFECTION LOW STEWART (US) 2026-02-26 — — WO disclosed
EP-4656722-A1 OR2AT4 RECEPTOR AGONIST APTAMERS AND USES THEREOF Fundacion Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz (ES) 2025-12-03 — — EP disclosed
CN-115996639-B Novel heteroaryl-triazole compounds as pesticides 拜耳公司 2025-06-13 — — CN disclosed
US-5861421-A 4,4-(disubstituted) cyclohexan-1-one monomers and related compounds SMITHKLINE BEECHAM CORPORATION (US) 1999-01-19 — — US disclosed
EP-0800393-A4 4,4-(DISUBSTITUTED)CYCLOHEXAN-1-ONE MONOMERS AND RELATED COMPOUNDS SMITHKLINE BEECHAM CORP (US) 1998-05-06 — — EP disclosed
EP-0800393-A1 4,4-(DISUBSTITUTED)CYCLOHEXAN-1-ONE MONOMERS AND RELATED COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1997-10-15 — — EP disclosed
WO-1996019995-A1 4,4-(DISUBSTITUTED)CYCLOHEXAN-1-ONE MONOMERS AND RELATED COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1996-07-04 — — WO disclosed
EP-0392745-B1 Immunoconjugates and prodrugs and their use in association for drug delivery CELLTECH LTD (GB) 1994-11-02 — — EP disclosed
WO-1990011782-A2 IMMUNOCONJUGATES AND PRODRUGS AND THEIR USE IN ASSOCIATION FOR DRUG DELIVERY CELLTECH LIMITED (GB) 1990-10-18 — — WO disclosed
EP-0392745-A2 Immunoconjugates and prodrugs and their use in association for drug delivery CELLTECH LIMITED (GB) 1990-10-17 — — EP disclosed
Send feedback